Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInspecs Group Regulatory News (SPEC)

Share Price Information for Inspecs Group (SPEC)

Share Price is delayed by 15 minutes
Get Live Data
96.50    12.00 (14.20%)
Bid:
95.00
Ask:
98.00
Spread: 3.00 (3.158%)
Market Cap: £98.11m
SPEC Live PriceLast checked at - London Stock Exchange

Intraday Inspecs Group Share Chart

Q3 Trading Update

28 Oct 2021 07:00

RNS Number : 4901Q
Inspecs Group PLC
28 October 2021
 

28 October 2021

 

Inspecs Group plc

("Inspecs", the "Company" or "the Group")

 

Q3 Trading Update

 

Inspecs Group plc, a leading designer, manufacturer and distributor of eyewear frames, today announces a trading update for the nine months to 30 September 2021.

 

The Group's strong trading performance delivered in the first half has continued into the third quarter with unaudited revenues for the nine months to 30 September 2021 of $185.0m (six months to 30 June 2021: $125.7m). The Board remains cautious of headwinds in the fourth quarter as COVID-19 continues to impact the global supply chain, but the Group remains confident in its full year outlook and notes the 2022 order book is in line with management's expectations.

 

 

For further information please contact:

 

Inspecs Group plc

Robin Totterman (CEO)

Chris Kay (CFO)

 

via FTI Consulting

Tel: +44 (0) 20 3727 1000

Peel Hunt (Nominated Adviser and Broker)

Adrian Trimmings

Andrew Clark

Tel: +44 (0) 20 7418 8900

 

FTI Consulting (Financial PR)

Alex Beagley

Fern Duncan

Alice Newlyn

Tel: +44 (0) 20 3727 1000

 

 

About Inspecs Group plc

 

INSPECS is a Bath-based designer, manufacturer and distributor of eyewear frames and optically advanced spectacle lenses. The Group produces a broad range of frames and lenses, covering optical, sunglasses and safety, which are either "Branded" (either under licence or under the Group's own proprietary brands), or "OEM" (including private label on behalf of retail customers and un-branded).

 

In December 2020, INSPECS acquired Eschenbach, a leading, global, eyewear supplier headquartered in Nuremberg, Germany, which includes the American company Tura. The acquisition extended the Group's presence internationally in key global markets. This followed the acquisition of lens maker Norville in July 2020, whereby INSPECS combined two heritage brands in British optical, Savile Row frame maker, and Norville lens maker, further enhancing its vertically integrated business model. As one of only a few companies that can offer this one-stop-shop solution to global retail chains, INSPECS is well positioned to continue to take market share in the globally expanding eyewear market.

 

INSPECS customers include global optical and non-optical retailers, global distributors and independent opticians, with its distribution network covering over 80 countries and reaching approximately 70,000 points of sale.

 

INSPECS has operations across the globe: with offices in the UK, Portugal, Scandinavia, the US and China (Hong Kong, Macau and Shenzhen), and manufacturing facilities in Vietnam, China, the UK and Italy. With the acquisition of Eschenbach, the Group's international reach further extends across Europe and the American markets.

 

The Group's growth strategy going forward is to: (i) continue to grow organically; (ii) undertake further acquisitions (and drive value through leveraging the Group's internal capabilities); and (iii) extend the Group's manufacturing capacity.

 

More information is available at www.INSPECS.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTQDLFLFBLZFBF
Date   Source Headline
16th Jun 20266:00 pmRNSCollaboration with Qualcomm Technologies
8th Jun 20267:00 amRNSPosting of Annual Report and Notice of AGM
19th May 20269:14 amRNSHolding(s) in Company
19th May 20267:00 amRNSBoard Changes
18th May 20267:00 amRNSBoard Changes
18th May 20267:00 amRNSOffer Closed
13th May 20267:00 amRNSFinal Results for the year ended 31 December 2025
1st May 20265:00 pmRNSClosure of the Offer
24th Mar 20267:00 amRNSAcceptance Level Update
18th Mar 202611:42 amRNSHolding(s) in Company
17th Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
17th Mar 20269:16 amRNSForm 8.3 - INSPECS GROUP PLC
17th Mar 20267:45 amRNSDisclosure Table
17th Mar 20267:45 amRNSDisclosure Table
17th Mar 20267:00 amRNSDay 21 Acceptance Level Update
17th Mar 20267:00 amRNSDay 21 Acceptance Level Update
16th Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
16th Mar 20268:44 amRNSForm 8.3 - INSPECS GROUP PLC
13th Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
13th Mar 20267:00 amRNSOffer Declared Unconditional
13th Mar 20267:00 amRNSOffer Declared Unconditional
11th Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
10th Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
10th Mar 202610:40 amRNSHolding(s) in Company
10th Mar 20268:54 amRNSForm 8.3 - INSPECS GROUP PLC
9th Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
9th Mar 20269:17 amRNSForm 8.3 - INSPECS GROUP PLC
6th Mar 20261:02 pmRNSForm 8.3 - Inspecs Group Plc
6th Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
6th Mar 20269:26 amRNSForm 8.3 - INSPECS GROUP PLC
5th Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
5th Mar 20269:32 amRNSForm 8.3 - INSPECS GROUP PLC
4th Mar 20265:00 pmRNSSatisfaction of NSIA Condition
4th Mar 20261:20 pmRNSAIM Rules Confirmation
4th Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
4th Mar 20269:30 amRNSForm 8.3 - INSPECS GROUP PLC
4th Mar 20268:34 amBUSForm 8.3 - Inspecs Group Plc
3rd Mar 20265:22 pmRNSHolding(s) in Company
3rd Mar 20264:38 pmRNSForm 8.3 - Inspecs Group PLC
3rd Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
2nd Mar 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
27th Feb 20261:09 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
26th Feb 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
25th Feb 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
25th Feb 20269:10 amGNWForm 8.3 - Inspecs Group Plc
23rd Feb 202612:00 pmRNSForm 8.5 (EPT/RI) Inspecs Group PLC
23rd Feb 202611:46 amRNSHolding(s) in Company
23rd Feb 202611:30 amRNSPublication of the Offer Document
20th Feb 20266:32 pmRNSSwitch to a Takeover Offer
20th Feb 20266:01 pmRNSSwitch to a Takover Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.